Supaporn SawadjoonPrasat KittakoopMasahiko IsakaKanyawim KirtikaraSiribhorn MadlaYodhathai ThebtaranonthMahidol UniversityThailand National Center for Genetic Engineering and Biotechnology2018-07-242018-07-242004-11-01Planta Medica. Vol.70, No.11 (2004), 1085-1087003209432-s2.0-9744238022https://repository.li.mahidol.ac.th/handle/20.500.14594/21136Two known spirodihydrobenzofuran terpenes (1 and 2) were isolated from a mycelium extract of the fungus Stachybotrys nephrospora BCC 3900. Compound 1 (Mer-NF5003F or stachybotrydial) exhibited potent antiviral activity (the IC50 value of 4.32 μg/mL) comparable to the standard drug, acyclovir, while compound 2 was inactive against the HSV-1 virus. Both 1 and 2 possessed antiplasmodial activity (IC50 values of 0.85 and 0.15 μg/mL for 1 and 2, respectively), and were not toxic towards the Vero cell line. A regiospecific conversion of the dialdehyde 1 to the lactone 2 proceeded simply under acidic conditions.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyChemistryMedicinePharmacology, Toxicology and PharmaceuticsAntiviral and antiplasmodial spirodihydrobenzofuran terpenes from the fungus Stachybotrys nephrosporaArticleSCOPUS10.1055/s-2004-832652